# Refining Cannabinoid Ratios for Geriatric Pain: Clinical and Methodological Insights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-ratios-geriatric-pain-optimization/ > **Published:** 2026-03-25T21:29:06-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:29-04:00 > **Clinical Summary:** Explore cannabinoid ratios geriatric pain for safer, effective cannabis-based pain management tailored to older adults' unique needs and sensitivities. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainAgingResearchDosingSafety Why This Matters Clinicians treating older adults with pain now have evidence-based guidance on optimized cannabinoid ratios, which is critical since geriatric patients often have altered pharmacokinetics and increased sensitivity to side effects compared to younger populations. The CARE study’s methodological framework enables more precise dosing and cannabinoid selection, potentially reducing adverse events like [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/) and falls that disproportionately harm elderly patients. This research translates to safer, more effective cannabis-based pain management for a vulnerable population that frequently faces inadequate analgesia from conventional analgesics alone. Clinical Summary The CARE study presents a methodological framework for optimizing cannabinoid ratios specifically in geriatric populations with chronic pain, addressing a significant gap in evidence since older adults are underrepresented in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) despite high prevalence of pain conditions and polypharmacy concerns. The research establishes that individualized cannabinoid ratios, rather than standardized formulations, may be necessary to achieve therapeutic benefit while minimizing adverse effects in seniors who often have altered pharmacokinetics and increased sensitivity to [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/). This work is clinically relevant because geriatric patients frequently experience cannabinoid-drug interactions and fall risk, making precision dosing and ratio selection critical safety considerations that current clinical practice guidelines do not adequately address. The study’s paradigm suggests that clinicians should move beyond one-size-fits-all dosing approaches and instead titrate THC to CBD ratios based on individual patient factors including age, comorbidities, and concurrent medications. For practitioners managing chronic pain in older adults, this research provides evidence-based guidance for more personalized cannabinoid selection, potentially improving efficacy and tolerability while reducing the risk of serious adverse events in a vulnerable population. Dr. Caplan’s Take “What the CARE study demonstrates is that we can no longer prescribe cannabis to elderly patients based on intuition or commercial product availability, the way we did a decade ago. The evidence increasingly shows that specific cannabinoid ratios produce measurably different clinical outcomes in older adults, which means we have an obligation to match patients to formulations with the same precision we’d apply to any other medication.” Clinical Perspective While cannabinoid ratio optimization for geriatric pain management represents a promising research direction, clinicians should recognize that the evidence base remains limited by small sample sizes, heterogeneous pain populations, and significant individual variability in [cannabinoid metabolism](https://cedclinic.com/fatty-acid-amide-hydrolase-obesity-risk-genetic-links/) among older adults. The CARE study’s methodological contributions are noteworthy, yet its findings may not generalize readily across different geriatric populations with comorbid conditions, polypharmacy concerns, or variable hepatic function that affect drug clearance. Older patients present particular complexity due to heightened sensitivity to psychoactive effects, increased fall risk, and potential drug-drug interactions with commonly prescribed medications like anticoagulants and sedatives. Until larger, pragmatic trials establish safety thresholds and optimal ratios for specific pain conditions in this population, clinicians considering [cannabinoid therapy](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/) for geriatric patients should start with conservative dosing, document baseline cognition and fall risk, and maintain 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/pain-management/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Refining+Cannabinoid+Ratios+for+Geriatric+Pain%3A+Methodological+and+Clinical+Reflections+on+...+%40drcaplan&url=https%3A%2F%2Fwww.dovepress.com%2Frefining-cannabinoid-ratios-for-geriatric-pain-methodological-and-clin-peer-reviewed-fulltext-article-JPR)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.dovepress.com%2Frefining-cannabinoid-ratios-for-geriatric-pain-methodological-and-clin-peer-reviewed-fulltext-article-JPR)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Refining+Cannabinoid+Ratios+for+Geriatric+Pain%3A+Methodological+and+Clinical+Reflections+on+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.dovepress.com%2Frefining-cannabinoid-ratios-for-geriatric-pain-methodological-and-clin-peer-reviewed-fulltext-article-JPR)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.dovepress.com/refining-cannabinoid-ratios-for-geriatric-pain-methodological-and-clin-peer-reviewed-fulltext-article-JPR](https://www.dovepress.com/refining-cannabinoid-ratios-for-geriatric-pain-methodological-and-clin-peer-reviewed-fulltext-article-JPR) Further Reading Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Evidence WatchChildhood Adversity Linked to Nearly Doubled Odds of Heart Attack in Adulthood Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Edible cannabis and pain, sleep, and mental health management in older adults](https://cedclinic.com/edible-cannabis-and-pain-sleep-and-mental-health-management-in-older-adults/) Explore how edible cannabis is used by older adults for managing pain, sleep disturbances, and mental health conditions with clinical insights. [Learn More](https://cedclinic.com/edible-cannabis-and-pain-sleep-and-mental-health-management-in-older-adults/) [Study Suggests Older Adults Prefer CBD or CBD/THC Combinations for Medicinal Cannabis](https://cedclinic.com/study-suggests-older-adults-prefer-cbd-or-cbd-thc-combinations-for-medicinal-cannabis/) This study highlights preferences among older adults for specific cannabinoid combinations, informing safer and effective therapeutic choices. [Read Study](https://cedclinic.com/study-suggests-older-adults-prefer-cbd-or-cbd-thc-combinations-for-medicinal-cannabis/) [Some Cannabinoids May Ease Common Chronic Pain Conditions, Study Finds](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) Review recent findings on cannabinoids' potential to alleviate chronic pain, supporting evidence-based approaches in clinical practice. [Explore Findings](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).